Status:

COMPLETED

Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborating Sponsors:

Johns Hopkins University

Conditions:

Breast Feeding

Opioid-Related Disorders

Eligibility:

FEMALE

18-40 years

Brief Summary

Methadone is a drug that offers significant therapeutic benefits to opiate dependent women who are pregnant. Currently, it is the treatment of choice for this group of people. The purpose of this stud...

Detailed Description

Methadone is a drug that is commonly used to treat opiate addiction, usually as part of a detoxification and maintenance program. Methadone offers significant therapeutic benefits to pregnant women wh...

Eligibility Criteria

Inclusion

  • Generally healthy methadone-maintained women electing to either exclusively breastfeed or bottle-feed their infants for 1 month after delivery

Exclusion

  • Relapse to illicit drugs or alcohol at any time during the study
  • Positive maternal or infant urine toxicology test at birth
  • Serious medical or psychiatric illness requiring medication or medical intervention
  • HIV infected
  • Currently dependent on alcohol
  • Major birth defect in the infant
  • Significant medical problems in the infant, including premature birth, sepsis, or other infections

Key Trial Info

Start Date :

November 1 2000

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

September 1 2005

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00218010

Start Date

November 1 2000

End Date

September 1 2005

Last Update

January 12 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Johns Hopkins University (BPRU) Bayview Campus

Baltimore, Maryland, United States, 21224 6823

Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2 | DecenTrialz